Literature DB >> 16378920

Additive value of contrast echocardiography for the diagnosis of noncompaction of the left ventricular myocardium.

Pasquale Gianfagna1, Luigi P Badano, Giorgio Faganello, Elena Tosoratti, Paolo M Fioretti.   

Abstract

Noncompaction of the left ventricular myocardium is a rare and unclassified cardiomyopathy that remains frequently overlooked, even by experienced echocardiographers. This fact may be due to non-optimal imaging of the lateral and apical myocardium, and/or insufficient disease awareness by echocardiographers. We report a case of a young man with heart failure and severe left ventricular dysfunction, previously diagnosed of ischemic etiology, in which the contrast enhancement of left ventricular endocardium allowed us to reach the correct diagnosis of isolated left ventricular noncompaction.

Entities:  

Mesh:

Year:  2006        PMID: 16378920     DOI: 10.1016/j.euje.2005.03.001

Source DB:  PubMed          Journal:  Eur J Echocardiogr        ISSN: 1532-2114


  4 in total

1.  Left ventricular noncompaction in an infant: use of non-ECG-gated cardiac CT.

Authors:  Hyun Woo Goo; In-Sook Park
Journal:  Pediatr Radiol       Date:  2006-12-14

2.  Familial apical dilated cardiomyopathy in a young man: a novel phenotype of Takatsubo syndrome or a new entity altogether?

Authors:  Dibbendhu Khanra; Yash Shrivastava; Bhanu Duggal; Kanwar Kumar Kapoor
Journal:  BMJ Case Rep       Date:  2019-07-27

3.  Incremental value of contrast echocardiography in the diagnosis of left ventricular noncompaction.

Authors:  Xiaoxiao Zhang; Li Yuan; Linli Qiu; Yali Yang; Qing Lv; Lin Li; Jing Wang; Lin He; Li Zhang; Xinfang Wang; Mingxing Xie; Xu Yu Jin
Journal:  Front Med       Date:  2016-12-23       Impact factor: 4.592

4.  Isolated noncompacted myocardium in an elderly patient.

Authors:  Eduardo de Paula Miranda; Lucas Alverne Freitas Albuquerque; Rubem Abitbol Menezes; Antonio Welington Silva; Lúcia de Sousa Belém; Fernando Pinheiro Ramos
Journal:  Clinics (Sao Paulo)       Date:  2008-08       Impact factor: 2.365

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.